Investment Opportunities from Israel March 2018 – For Hong Kong Investors

 

Israeli companies are looking for investments from Hong Kong!  If you are interested in any of the below Israeli companies, please contact Winkie at winkie.lui@israeltrade.gov.ilInvestment info, company info and product info are available.

======================================================

 1) OrthoKinematica www.orthokinematica.com

OrthoKinematica has developed an artificial cervical disc, backed by two strong patents, having CE Mark, implanted in Patients in Germany with 100% success; first implants are over eight years, with full success and satisfaction of all patients and doctors. Our disc is, so far, the only artificial cervical disc which fully emulate the natural disc with ALL its functions – Range of motion (all artificial discs are doing), Attenuation (resistance to the move on all three axis at same time – only our disc is doing like the natural disc) and elevating the height between vertebrae (only our disc is doing like the natural disc).  At this stage, the company is developing, the second generation of the product to be made of innovative material combination.

CerKinetic cTDR Technology

The CerKinetic cTDR is a weight-bearing implant intended for use as a cTDR within the intervertebral spaces, harboring a degenerated disc at levels between C3 to C7 in the cervical column. The prosthesis, which enables motion preservation within the implanted inter-space in a near normal kinematic mode, restoring and maintaining intervertebral height and preserving cervical spine column alignment. The implant consists of two components. Each component presents two surface areas, external and internal:

THE INTERNAL SURFACES

The internal surfaces are designed to be coupled (Figure 4.13) with their contra-lateral parts, jointly forming the bearing mechanism of the implant (Figure 4.11 and 4.12).

 

2) Thomas Medical

Thomas Medical has developed a new technology for the treatment of Sleep Apnea. The company has concluded successfully, a clinical study for the purpose of “Proof of Concept”, and now shall develop the final first generation of this product.  A second product with the same technology, will be for stopping snoring, which was also proved in the clinical study.

The company will get to the market with the first product (for Sleep Apnea) in the middle of 2019 and the second product, for snoring, at the beginning of 2020.

Thomas Medical Apnea Therapy Device

  1. Stent inserted in a compressed state, not touching base of tongue
  2. Stent is automatically spread out only after the patient is asleep
  3. Stent is spread out very slowly allowing the nerves to habituate and decrease reaction
  4. Stent is collected back to compressed state before patient awakes.
  5. Hide stent inside device. Patient doesn’t see the stent full size.
  6. Prevent user from removing the device from mouth if stent is visible (as much as possible).
  7. Use the terminology “tongue support” instead of “stent”